Search clinical trials for: Reference treatment : Nicotine transdermal patch

Total 642 results

The University of Texas Health Science Center,...

Recruiting

Exenatide for Smoking Cessation and Prevention of Weight Gain

Smoking Cessation | Weight Gain

United States
The University of Texas Health Science Center,...

Completed

Exenatide Once Weekly for Smoking Cessation

Smoking Cessation

United States
Cerevel Therapeutics, LLC

Recruiting

A Study Evaluating the Pharmacokinetics and Relative Bioavailability of Emraclidine Immediate-Release Tablets in Healthy Adult Participants

Healthy Participants

United States
Luye Pharma Group Ltd.

Completed

A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro

Parkinson Disease

United States
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); CIHR Canadian HIV Trials Network

Unknown

The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers (CANQUIT)

Smoking Cessation | HIV

Canada
Memorial Sisli Hospital, Istanbul

Completed

The Effects of Estrogen on Artificial Endometrium

Infertility

Turkey
Novartis Pharmaceuticals

Completed

Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease. (CARE)

Alzheimer's Disease

Turkey, Australia, Thailand, Korea, Republic of, Malaysia
Purdue Pharma LP

Completed

Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension Phase

Osteoarthritis

United States
University of North Carolina, Chapel Hill
National Institute of Mental Health (NIMH)

Terminated

The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood (Changes)

Stress, Emotional | Perimenopausal Disorder

United States
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Effects of Resveratrol and Acute Exercise on Endothelial Function in Postmenopausal Women

Endothelial Dysfunction

United States
Gilead Sciences

Completed

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis (ASTRAL-4)

Hepatitis C Virus Infection

United States, Puerto Rico
M.D. Anderson Cancer Center
National Institute of Mental Health (NIMH)

Active, not recruiting

Smoking Cessation for Depressed Smokers

Depression | Smoking

United States
Brown University
National Cancer Institute (NCI)

Completed

Development of Positive Psychotherapy for Smoking Cessation

Smoking

United States
National Institute on Drug Abuse (NIDA)

Completed

Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke

Psychotic Disorders | Schizophrenia | Tobacco-Use Disorder

United States
Southern Illinois University Carbondale
National Institute on Drug Abuse (NIDA)

Completed

Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers

Nicotine Dependence

United States
University of Wisconsin, Madison
National Cancer Institute (NCI); University of Illinois at Chicago; Penn State...

Completed

Motivation Project: Testing Intervention Components for the Smoker Who is Unwilling to Quit

Smoking | Smoking Cessation | Motivation

United States
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Clinical Study on the Effect of Tizanidine on the Function and Pain of Patients After Shoulder Arthroscopy

Rotator Cuff Tears
Abbott Medical Devices

Completed

Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System (CONTACT_AFL)

Typical Atrial Flutter

United States, Canada
Jiangxi University of Traditional Chinese Medicine

Active, not recruiting

A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community

Primary Hypertension

China
Novartis Pharmaceuticals

Terminated

Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment (EXCITING)

Multiple Sclerosis | Cognitive Impairment

Germany
Novartis

Completed

An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Alzheimer's Disease
Mundipharma AB

Completed

Norspan Efficacy and Safety Among Elderly Subjects

Osteoarthritis Pain of the Hip and or Knee

Sweden
UCB Pharma

Completed

Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the Body

Healthy Volunteers

Germany
Georgetown University

Recruiting

Tobacco Education and Lung Health Study (TEAL) (TEAL)

Smoking Cessation

United States
University of Pennsylvania

Completed

PATH For Triples Study: Medication and Lifestyle Adherence for HIV+ Patients (PFT)

HIV

United States
Duke University

Completed

Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking

Alcohol Drinking | Smoking Cessation

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Active, not recruiting

Metabolism Informed Smoking Treatment: The MIST RCT

Smoking

United States
Johns Hopkins University
National Institute on Aging (NIA)

Terminated

Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment (ANXPD)

Parkinson Disease | Anxiety Disorders

United States
Purdue Pharma LP

Completed

Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study

Chronic Nonmalignant Pain

United States
Purdue Pharma LP

Completed

Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods

Healthy

United States
Novartis

Completed

A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA) (EXTRA)

Alzheimer's Disease

France
Novartis Pharmaceuticals

Completed

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Dementia, Alzheimer Type | Alzheimer's Disease

Poland, Taiwan, United States, Israel, Denmark, Korea, Republic of, Peru, Russian Federation, Chile, Italy, Mexico, Norway, Sweden, Slovakia, Czechia, Portugal, Finland, Guatemala, Germany, Puerto Rico, Venezuela
Novartis Pharmaceuticals
Ono Pharmaceutical Co. Ltd

Completed

Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Japan
University of Nottingham

Unknown

The Efficacy of Nitric Oxide in Stroke (ENOS) Trial (ENOS)

Stroke

United Kingdom
VA Office of Research and Development

Completed

Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH) (MESH)

Smoking | Human Immunodeficiency Virus

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers

Tobacco Use Cessation | Cancer Prevention

United States
US Department of Veterans Affairs

Completed

Combinations of Pharmacologic Smoking Cessation Treatments

Smoking

United States
Novartis Pharmaceuticals
Ono Pharmaceutical Co. Ltd

Completed

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors

Alzheimer's Disease

Japan
Purdue Pharma LP

Terminated

Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.

Osteoarthritis

United States
University of Texas at Austin

Completed

Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine (DCS/PSRT)

Panic Attack | Nicotine Addiction

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Active, not recruiting

BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study

Smoking Cessation | Smoking, Cigarette | Quitting Smoking

United States
Agile Therapeutics

Completed

Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches (ATI-CL21)

Healthy
Johnson & Johnson Pharmaceutical Research & Development...

Completed

The Effect of an Adhesive Overlay on the Delivery of Contraceptive Hormones From ORTHO EVRA® in Healthy Women

Healthy Volunteers

United States
Mundipharma Pharmaceuticals Sdn. Bhd.

Completed

Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity

Osteoarthritis | Rheumatoid Arthritis | Lower Back Pain | Joint Pain | Muscle Pain

Malaysia
Purdue Pharma LP

Terminated

Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase

Osteoarthritis

United States
Purdue Pharma LP

Terminated

Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015

Back Pain Lower Back Chronic

United States
Durect

Completed

Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia

Pain | Postherpetic Neuralgia

United States
Purdue Pharma LP

Completed

Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee

Osteoarthritis

United States
University of Southern California
National Cancer Institute (NCI)

Terminated

Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy

Breast Cancer | Nausea | Vomiting

United States
NuPathe Inc.

Completed

Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers (NP101-006)

Migraine Disorders

United States

Search clinical trials for: Reference treatment : Nicotine transdermal patch

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations